The association between regular use of aspirin and the prevalence of prostate cancer: Results from the National Health Interview Survey

Wan Ting Huang, Steven R. Erickson, Richard A. Hansen, Chung Hsuen Wu

研究成果: 雜誌貢獻文章

3 引文 (Scopus)

摘要

Prostate cancer is prevalent with significant morbidity in the United States. Aspirin previously has been found to be associated with reduced carcinogenesis of prostate cells. However, it remains unclear whether regularly taking aspirin could lower the risk of prostate cancer. Therefore, our aim was to examine the association between self-reported regular use of aspirin and the prevalence of prostate cancer in a national sample of the US adult population.The National Health Interview Survey is an annual survey conducted by the National Center for Health Statistics to investigate health and healthcare use of the US population. The current study is a population-based cross-sectional study using the 2010 National Health Interview Survey data. Adult male respondents who self-reported regularly taking aspirin at least 3 times per week were grouped as regular users. The prostate cancer prevalence was measured by respondents' self-report of prostate cancer. Multivariable logistic regression models were used to evaluate the association between these 2 factors by adjusting for covariates selected based on Andersen Behavioral Model of Health Services Use.An estimated 23 million (23.7%) males in the United States reported that they took aspirin regularly. Of them, 5.0% had prostate cancer. Regular aspirin use was significantly associated with a lower self-reported prevalence of prostate cancer after adjusting for predisposing, enabling, and need factors (odds ratio 0.60, 95% confidence interval 0.38-0.94).Regular aspirin use was found to be significantly associated with a lower self-reported prevalence of prostate cancer in the United States in 2010. Further clinical trials and longitudinal studies are needed to confirm the causality between regular aspirin use and prostate cancer.
原文英語
頁(從 - 到)e3909
期刊Medicine
95
發行號25
DOIs
出版狀態已發佈 - 六月 1 2016

指紋

Health Surveys
Aspirin
Prostatic Neoplasms
Interviews
Causality
Logistic Models
National Center for Health Statistics (U.S.)
Population
Self Report
Health Services
Longitudinal Studies
Prostate
Carcinogenesis
Cross-Sectional Studies
Odds Ratio
Clinical Trials
Confidence Intervals
Morbidity
Delivery of Health Care
Health

ASJC Scopus subject areas

  • Medicine(all)

引用此文

The association between regular use of aspirin and the prevalence of prostate cancer : Results from the National Health Interview Survey. / Huang, Wan Ting; Erickson, Steven R.; Hansen, Richard A.; Wu, Chung Hsuen.

於: Medicine, 卷 95, 編號 25, 01.06.2016, p. e3909.

研究成果: 雜誌貢獻文章

@article{4a998ac77271459aa3f1905daaa29524,
title = "The association between regular use of aspirin and the prevalence of prostate cancer: Results from the National Health Interview Survey",
abstract = "Prostate cancer is prevalent with significant morbidity in the United States. Aspirin previously has been found to be associated with reduced carcinogenesis of prostate cells. However, it remains unclear whether regularly taking aspirin could lower the risk of prostate cancer. Therefore, our aim was to examine the association between self-reported regular use of aspirin and the prevalence of prostate cancer in a national sample of the US adult population.The National Health Interview Survey is an annual survey conducted by the National Center for Health Statistics to investigate health and healthcare use of the US population. The current study is a population-based cross-sectional study using the 2010 National Health Interview Survey data. Adult male respondents who self-reported regularly taking aspirin at least 3 times per week were grouped as regular users. The prostate cancer prevalence was measured by respondents' self-report of prostate cancer. Multivariable logistic regression models were used to evaluate the association between these 2 factors by adjusting for covariates selected based on Andersen Behavioral Model of Health Services Use.An estimated 23 million (23.7{\%}) males in the United States reported that they took aspirin regularly. Of them, 5.0{\%} had prostate cancer. Regular aspirin use was significantly associated with a lower self-reported prevalence of prostate cancer after adjusting for predisposing, enabling, and need factors (odds ratio 0.60, 95{\%} confidence interval 0.38-0.94).Regular aspirin use was found to be significantly associated with a lower self-reported prevalence of prostate cancer in the United States in 2010. Further clinical trials and longitudinal studies are needed to confirm the causality between regular aspirin use and prostate cancer.",
author = "Huang, {Wan Ting} and Erickson, {Steven R.} and Hansen, {Richard A.} and Wu, {Chung Hsuen}",
year = "2016",
month = "6",
day = "1",
doi = "10.1097/MD.0000000000003909",
language = "English",
volume = "95",
pages = "e3909",
journal = "Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "25",

}

TY - JOUR

T1 - The association between regular use of aspirin and the prevalence of prostate cancer

T2 - Results from the National Health Interview Survey

AU - Huang, Wan Ting

AU - Erickson, Steven R.

AU - Hansen, Richard A.

AU - Wu, Chung Hsuen

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Prostate cancer is prevalent with significant morbidity in the United States. Aspirin previously has been found to be associated with reduced carcinogenesis of prostate cells. However, it remains unclear whether regularly taking aspirin could lower the risk of prostate cancer. Therefore, our aim was to examine the association between self-reported regular use of aspirin and the prevalence of prostate cancer in a national sample of the US adult population.The National Health Interview Survey is an annual survey conducted by the National Center for Health Statistics to investigate health and healthcare use of the US population. The current study is a population-based cross-sectional study using the 2010 National Health Interview Survey data. Adult male respondents who self-reported regularly taking aspirin at least 3 times per week were grouped as regular users. The prostate cancer prevalence was measured by respondents' self-report of prostate cancer. Multivariable logistic regression models were used to evaluate the association between these 2 factors by adjusting for covariates selected based on Andersen Behavioral Model of Health Services Use.An estimated 23 million (23.7%) males in the United States reported that they took aspirin regularly. Of them, 5.0% had prostate cancer. Regular aspirin use was significantly associated with a lower self-reported prevalence of prostate cancer after adjusting for predisposing, enabling, and need factors (odds ratio 0.60, 95% confidence interval 0.38-0.94).Regular aspirin use was found to be significantly associated with a lower self-reported prevalence of prostate cancer in the United States in 2010. Further clinical trials and longitudinal studies are needed to confirm the causality between regular aspirin use and prostate cancer.

AB - Prostate cancer is prevalent with significant morbidity in the United States. Aspirin previously has been found to be associated with reduced carcinogenesis of prostate cells. However, it remains unclear whether regularly taking aspirin could lower the risk of prostate cancer. Therefore, our aim was to examine the association between self-reported regular use of aspirin and the prevalence of prostate cancer in a national sample of the US adult population.The National Health Interview Survey is an annual survey conducted by the National Center for Health Statistics to investigate health and healthcare use of the US population. The current study is a population-based cross-sectional study using the 2010 National Health Interview Survey data. Adult male respondents who self-reported regularly taking aspirin at least 3 times per week were grouped as regular users. The prostate cancer prevalence was measured by respondents' self-report of prostate cancer. Multivariable logistic regression models were used to evaluate the association between these 2 factors by adjusting for covariates selected based on Andersen Behavioral Model of Health Services Use.An estimated 23 million (23.7%) males in the United States reported that they took aspirin regularly. Of them, 5.0% had prostate cancer. Regular aspirin use was significantly associated with a lower self-reported prevalence of prostate cancer after adjusting for predisposing, enabling, and need factors (odds ratio 0.60, 95% confidence interval 0.38-0.94).Regular aspirin use was found to be significantly associated with a lower self-reported prevalence of prostate cancer in the United States in 2010. Further clinical trials and longitudinal studies are needed to confirm the causality between regular aspirin use and prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=85011772720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011772720&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000003909

DO - 10.1097/MD.0000000000003909

M3 - Article

C2 - 27336878

AN - SCOPUS:85011772720

VL - 95

SP - e3909

JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

SN - 0025-7974

IS - 25

ER -